Oracle's 5-year credit default swaps are tumbling after the company announced a $50 billion debt and equity financing plan.

Jason Maynard named CEO at Qualtrics; Jenny Lay-Flurrie gets a new gig at Microsoft; and more key personnel changes.

Over the past decade, Oracle stock (NYSE: ORCL) has emerged as a premier capital-return engine, distributing a remarkable ...

Feb ‌1 (Reuters) - ​Oracle ‌said it ​expects ‍to ​raise $45 ​billion to $50 ⁠billion in ‌2026 to ​build additional ‌capacity ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Market open and close ceremonies take place daily at the Nasdaq MarketSite Studio in Times Square and around the globe. Executives from Recursion (Nasdaq: RXRX), a leading clinical stage TechBio ...

Welcome back! The dollar is down and gold is up, prompting chatter about a “sell America” trade. At Breakingviews, we don’t see much evidence of it. Let us know what we’re missing. Was this newsletter ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Access detailed historical stock prices, including daily closing prices, for RXRX. Analyze past performance trends, track price movements, and explore historical data to inform your investment ...